Imatinib Completed Phase N/A Trials for Brain and Central Nervous System Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00401024Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma